Company / Working Capital
Catalyst Pharmaceuticals Partners, Inc. Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$746.9M
FY2025
5-year range
$143.3M / $746.9M
FY2021-FY2025
Trend
+48.5%
vs FY2024
Sector context
#58 of 213
Health Care
What the data says
At $747M, Catalyst Pharmaceuticals Partners, Inc.'s working capital ranks #58 of 213 in the Health Care sector. Working Capital has fluctuated over the past 10 years, ranging from $39M in FY2016 to $747M in FY2025.
Based on SEC 10-K filings.
$747M in FY2025 with a 5-year CAGR of +40.5%.
Improved from $143M to $747M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +41.6%
- 5-Year CAGR
- +40.5%
- 10-Year CAGR
- -
Sector benchmark
#58 of 213 in Health CareTop 27% of 213This company $746.9M Sector average $934.6M
▼
-20.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +40.5%, indicating consistent growth.
- In FY2025, working capital increased 48.5% year-over-year.
- Ranks #58 out of 213 companies in the Health Care sector.
- Lowest working capital in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 4.78 (safe zone, above 2.9 threshold)
- Strong profit margin: 33.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $746.9M | +48.5% |
| FY2024 | $502.9M | +251.0% |
| FY2023 | $143.3M | -45.6% |
| FY2022 | $263.2M | +43.8% |
| FY2021 | $183.0M | +34.1% |
| FY2020 | $136.5M | +56.4% |
| FY2019 | $87.3M | +91.1% |
| FY2018 | $45.7M | -43.6% |
| FY2017 | $80.9M | +105.6% |
| FY2016 | $39.4M | -30.3% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026